UChicago Medicine
J

Update on Immunotherapy Efforts in cHL and DLBCL

By UChicago Medicine FEATURING Justin Kline
By UChicago Medicine FEATURING Justin Kline
222 views
August 19, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Related Videos

International Congress on Cancer Metastasis

10th International Congress on Cancer Metastasis

Wed, Oct 29, 2025
26:59

ASH 2024 Review: Key Updates in Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

M. Gallogly

432 views
33:01

2024 Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

464 views
11:49

ASH 2025 Review: Updates in Frontline & R/R DLBCL

University of Colorado Division of Hematology

M. Kamdar

210 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
14:56

ASH 2024 Insights: POLARIX 5yr Update - Pola-R-CHP vs. R-CHOP in 1L …

2024 ASH Annual Meeting Insights Hub

G. Salles

240 views
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.8K views
08:44

ASH 2024 Insights: Incorporating Nivolumab and Brentuximab Vedotin I…

2024 ASH Annual Meeting Insights Hub

A. LaCasce

275 views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

233 views
10:00

ASH 2024 Insights: Pembro Maintenance instead of ASCT for Pts With R…

Memorial Sloan Kettering Cancer Center

A. Moskowitz

221 views
18:41

ASH & ISHL 2024 Summary: Key Clinical Questions & Highlights in cHL

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

178 views
22:14

Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy

Remy Dulery

315 views
10:27

Sequencing Cellular Therapy and Bispecific Antibodies in DLBCL

Megan Melody

248 views
10:52

Current Treatment of 1L Hodgkin Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

600 views
09:17

ASH 2024 Insights: Outcomes With Bispecific Antibodies Post-CAR T-Ce…

2024 ASH Annual Meeting Insights Hub

M. Melody

185 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

604 views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

618 views
11:43

Updates on Approved CAR-Ts for Lymphomas

Moffitt Cancer Center

J. Chavez

142 views
10:09

Tafasitamab + Lenalidomide in R/R DLBCL: Updated Results From the L-…

David Bond

159 views
15:26

Golcadomide + R-CHOP in High-Risk, Untreated Aggressive B-Cell Lymph…

Moffitt Cancer Center

Y. Zhang, B. Shah, J. Chavez, M. Jain, S. Gaballa

102 views
07:57

ASH 2024 Insights: Timing of CAR-T Failure as a Predictor of Outcome…

2024 ASH Annual Meeting Insights Hub

E. Shumilov

106 views
AUTOPLAY